Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.
about
Cryptococcus neoformans: Tripping on Acid in the PhagolysosomeDancing cheek to cheek: Cryptococcus neoformans and phagocytesUnique characteristics of cryptococcosis identified after death in patients with liver cirrhosis: comparison with concurrent cohort diagnosed antemortem.Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosisInvasive fungal infections after renal transplantation.Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsHow sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs.DNA mutations mediate microevolution between host-adapted forms of the pathogenic fungus Cryptococcus neoformans.Invasive fungal infections in solid organ transplant recipients.Potential contribution of fungal infection and colonization to the development of allergy.Targeted versus universal antifungal prophylaxis among liver transplant recipientsTreatment principles for Candida and Cryptococcus.IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.Cluster of Cryptococcus neoformans Infections in Intensive Care Unit, Arkansas, USA, 2013.Comparative analyses of clinical and environmental populations of Cryptococcus neoformans in Botswana.Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannanCryptococcosis in solid organ transplant recipients: current state of the scienceCryptococcus: from environmental saprophyte to global pathogen.Mechanisms of cryptococcal virulence and persistence.Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.Cryptococcal Disease in HIV-Infected Children.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.Global Reprogramming of Host Kinase Signaling in Response to Fungal Infection.A pseudo-outbreak of disseminated cryptococcal disease after orthotopic heart transplantation.Cellulitis in a Liver Transplant Patient as an Initial Manifestation of Disseminated Cryptococcal DiseaseMolecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.Uncommon mycosis in a patient with diabetes.Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice.Cryptococcosis-related deaths and associated medical conditions in the United States, 2000-2010.Disseminated cryptococcosis presenting initially as lower limb cellulitis in a renal transplant recipient - a case report.Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection.Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children.Variability in innate host immune responses to cryptococcosis.Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH.
P2860
Q26765874-FA5714BB-41FF-481A-B9FB-49C69E34DEBEQ26798926-4079C11F-890E-42E0-816A-F45161239F96Q30275986-6193AE39-948F-41EB-8526-7FBA60F5F040Q30426041-19A3DA50-6CB4-4F6E-BA01-ACE75EC0D62BQ33871837-71D84E25-4531-48CD-924C-395FB1F5B2DAQ33891744-53377D90-2CA0-4CC3-AF73-177BC4387223Q33894565-8807FEC6-ADB4-413C-A5CA-12D8FF075BD8Q34020746-3724A965-0C0B-4329-A737-25017FA96E4EQ34033551-1C976C1D-E439-4169-9D3B-8C8154194886Q34440643-6C794634-AFA3-4554-AC43-E91120E0B364Q34461693-CE9A3CCF-2DB6-4350-9A67-7B3382710D2AQ34977170-B7A833A0-74B9-4A97-90ED-ED6C2E26BF5CQ35194743-9206C45A-462F-4701-8683-56DD144AC5A9Q35664186-A40C95EA-C300-429D-8E64-1DB4A07E4A10Q35952109-7109EAF7-24B2-4EC4-B1E1-477D4B60C311Q36121559-66DF751F-53BE-4DBA-B217-F802EA58DD75Q36592845-06E9BC9F-BBF6-45CC-9A20-C2117AF545A9Q36844895-64D6A317-12B5-4432-A56D-24EF50485B40Q37226750-B2A9C5E0-7EE6-43B4-9DA4-B2EF3A5FC2BCQ37250158-D0B0C84B-D565-4854-A80F-59F6C9983A5EQ37781066-1873CE12-C7A2-4C42-8B5F-465A39B53648Q37949657-0788272D-9AD8-4CA3-A31C-1A5797EBB8FFQ38011299-6256334C-04E3-4776-A5DA-1F588DE9E68EQ38558078-121CCBCA-B1FC-45F5-9E8F-07526F1FAB87Q38904619-B3DF77BE-7D57-4935-91AA-41CA5105BD91Q38965488-72E3DC25-5AA7-4881-AFC4-FDA2ECD0BB3FQ40216961-E9ECA4AE-7FC7-46E0-BE47-D1CECB5EFA97Q40252526-28A7445E-BB13-4E66-AC9C-01AF608ADADFQ40366255-5C0C1A8F-3779-468B-9BBA-FA6E6CB8B07BQ40721637-DEF190CB-AB9F-4B5D-AEBD-777A131A8D2DQ40776630-E3D5F0A1-F066-41D2-AAF7-7615A96B6EDBQ42148349-D3A1A622-1114-437B-9259-9D0EF5C5D761Q42199260-BC9113FB-C68F-4A43-80D0-96FBDF24D6D0Q48157142-D731BA9F-D42E-4924-87BB-FC1FFACE3E61Q49537152-2E6E793A-33E9-47B6-B1DF-9527C5A1FCF7Q53398307-94C32DBE-E9E3-49E7-A654-F181574C3C1EQ55400028-63E634F6-E90B-4EE4-96E5-AD5F64682209Q55432589-31BB2AB8-59A3-4559-881D-73E08148F69D
P2860
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Serologic evidence for reactiv ...... d-organ transplant recipients.
@ast
Serologic evidence for reactiv ...... d-organ transplant recipients.
@en
type
label
Serologic evidence for reactiv ...... d-organ transplant recipients.
@ast
Serologic evidence for reactiv ...... d-organ transplant recipients.
@en
prefLabel
Serologic evidence for reactiv ...... d-organ transplant recipients.
@ast
Serologic evidence for reactiv ...... d-organ transplant recipients.
@en
P2093
P2860
P356
P1476
Serologic evidence for reactiv ...... d-organ transplant recipients.
@en
P2093
A Casadevall
A P Limaye
D L Goldman
T L Pruett
P2860
P304
P356
10.1128/CVI.00242-07
P577
2007-10-24T00:00:00Z